Global Reagents Markets Project Strong Growth Through 2033
Biotech reagents market projected to hit $148.21B by 2030; life science reagents to reach $114.4B by 2033. Growth driven by precision diagnostics, genomics, and personalized medicine.
Abbott Laboratories
CompanyCompany Profile
Abbott Laboratories is an American multinational healthcare company headquartered in Abbott Park, Illinois. Founded in 1888, it operates across pharmaceuticals, diagnostics, nutrition, and medical devices.
- Website
- https://www.abbott.com
- Headquarters
- Abbott Park, Illinois, USA
- Founded
- 1888
- Stock Ticker
- NYSE:ABT
Related News
Pharmaceutical Stocks to Watch Include Eli Lilly, AbbVie, Vertex, Gilead and Pfizer
Eli Lilly, AbbVie, Vertex, Gilead Sciences and Pfizer were identified as pharmaceutical stocks to watch, with Abbott Laboratories and McKesson appearing on a separate seven-stock list.
Healthcare stocks face 2026 policy headwinds as capex rankings highlight sector differences
Healthcare stocks were described as a defensive sector facing 2026 reimbursement headwinds, while capex rankings showed HCA Healthcare, Johnson & Johnson and Merck at the top. The sources also highlighted how capex differs across providers, device makers and drug developers.
AbbVie's Pipeline Growth and Dividend Track Record Draw Long-Term Investors
AbbVie has successfully transitioned from Humira dependence to growth driven by Skyrizi and Rinvoq, while maintaining a 54-year dividend increase streak and expanding its pipeline to roughly 90 programs through strategic acquisitions.
Precision Medicine Market Projected to Reach $329.73 Billion by 2033
The global precision medicine market reached $98.87 billion in 2024 and is projected to grow at 14.8% CAGR through 2033, driven by genomic sequencing advances, chronic disease prevalence, and AI-driven diagnostics adoption.